Clin2
NCT07819825Worth exploringNot yet recruiting

Artemisia herb tea for silent malaria infection

Asymptomatic P.Falciparum Malaria

Part of Infections clinical trials.

This trial tests an herbal tea made from the plant Artemisia annua to treat malaria that is present in your blood but causes no symptoms. The goal is to see if it can safely clear the infection.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
20 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You are between 18 and 45 years old
  • You have been living in a malaria-endemic area for at least 5 years
  • You are currently infected with malaria but have no symptoms (like no fever)
  • You have not taken antimalarial drugs in the last 28 days
  • You are free from other major medical conditions

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05801198Not yet recruiting· Phase 2
Clearing hidden malaria to help eliminate the disease in Rwanda

This study tests a way to clear hidden malaria parasites in people who don't feel sick, to help stop the spread of malaria in Rwanda.

NCT05750628Recruiting· Phase 2
Testing malaria medicines in uncomplicated falciparum malaria

This trial studies how well and how safely different anti-malaria medicines work for people who have uncomplicated malaria caused by Plasmodium falciparum. You may be eligible if you have a confirmed infection with a certain parasite level and do not have signs of severe disease or major health conditions.

Banfora
NCT07840898Not yet recruiting
Malaria treatment study in Ethiopia

This study tests how well malaria treatments work in Ethiopia. It aims to find the best medicines for uncomplicated malaria caused by certain parasites, helping patients recover fully and preventing future drug resistance.

Addis Ababa
NCT05951595Recruiting· Phase 3
Testing three malaria medicines together versus two

This study compares a combination of three medicines to treat uncomplicated malaria, to see if it works as well and is as well tolerated as a two-medicine combination. You may join if you have a specific type of malaria infection in a mild form and meet safety requirements.

Ruhuha, Eastern Province
NCT07811908Recruiting· Phase 2
Testing a new malaria treatment for children

This study tests a new malaria treatment for children with mild (uncomplicated) malaria. The goal is to see if the treatment safely and effectively clears the infection.

Banfora
NCT06862453Recruiting· Phase 1
Safety of a new malaria vaccine in healthy adults

This study tests a new malaria vaccine in healthy adults. You will receive the vaccine and then be exposed to the malaria parasite in a controlled setting to check if the vaccine protects you.

Tübingen

Hear when a new Asymptomatic P.Falciparum Malaria trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.